Scott Glaser
@DocGlaser
Followers
2K
Following
3K
Media
45
Statuses
511
Oncologist | Chief of #Brachytherapy and Gyn #radonc at @cityofhope | Views are my own
Durate, CA
Joined February 2012
RT @Sushilberiwal: First Hybrid brachytherapy with Aarhus applicator in chicoutimi hospital, Quebec @AmericanBrachy on brachy awareness day….
0
8
0
Congrats!.
Join us in celebrating the remarkable achievements of our 2025 #ABSFellows. These exceptional individuals are the epitome of brilliance, passion, and commitment to making a positive impact in the field of #brachytherapy. @TimShowalter1 @SanghviMd @UCSDRadMed @MedicineUVA
0
0
5
RT @PBlanchardMD: Reassuring toxicity data from PCS IX trial after hypofractionated (5*5 Gy) pelvic & prostate #radiotherapy priori to #bra….
0
16
0
RT @PBlanchardMD: STORM-PEACE V trial reported by @ZilliThomas #ESTRO25. Pelvic ENI superior to MDT for pelvic relapses after local Tx for….
0
42
0
RT @Sushilberiwal: Isotoxic FLAME shows 15% BCR difference with 10 years follow up with significant difference in local and regional recurr….
0
13
0
RT @GiuliaMarvaso84: Elective para-aortic RT + 24 months ADT shows promising results in pN1 prostate cancer! In the PART trial (n=96), 5y c….
0
40
0
RT @Sushilberiwal: Best #ESTRO2025 abstract for EMBRACE2 showing excellent locoregional control and significantly reduced morbidity compare….
0
11
0
RT @cancerphysicist: PLATO ACT 4 results for dose de-escalation in early-stage anal cancer are out! Prof Sebag-Montefiore presents on the p….
0
20
0
RT @Sushilberiwal: Danish data with longer follow up shows no difference in lymphedema or LRR with RNI hypofractionation @Icro_Meattini @Er….
0
13
0
So cool to see you improve cancer care around the world!.
1
3
13
Congrats @yunroseli !.
Congrats to Dr Rose Li and Co-PI Dr. June Rhee on their 3 year AHA Collaborative Sciences Award of $1M to investigate cardiometabolic toxicity in men with prostate cancer receiving ADT using deep molecular characterization through multi-omics methods! #radonc #multiomics
1
0
5
Congrats Jeff! Very impressive and inspiring!.
Congrats to Dr. Jeff Wong (and Co-PIs Jack Shively/Flavia Pichiorri), on yet another @theNCI R01 grant focused on #theranostics this time testing anti-CD38 targeted alpha radiopharmaceutical therapy with TMLI & chemo in pts with refractory/relapsed AML‼️ Well done Jeff! #radbio
0
0
3
RT @TeWilliamsMD: We are excited to have you join the phenomenal @COH_RadOnc team Eemon and Tomiwa! Congratulations! 🎉🥳 Another highly suc….
0
3
0
RT @cityofhope: Time’s running out! The deadline to vote in the @usnews #BestHospitals survey is March 23. Join @TeWilliamsMD and vote for….
0
3
0
Way to go @ColtonLadbury!!! We @COH_RadOnc are so happy to have you providing such great care @cityofhope!.
Very excited that we have successfully implemented hybrid interstitial brachytherapy at @cohoc_radonc! A critical step to providing top-level brachytherapy for gynecological malignancies in Orange County #radonc #thisisbrachytherapy
1
3
19
Way to go @HMcGeeMDPhD !.
Genetic Variation and Regulation of MICA in Early-Onset Colorectal Cancer - @HMcGeeMDPhD . @cityofhope @ColtEgelston @yasminkmdphd @CaboFishDoc @TeWilliamsMD . #Cancer #Crcsm #GIOnc #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology.
0
1
4
RT @Sushilberiwal: Podcast on substantial LVSI in setting of nodal assessment @KamravaMD @DocGlaser @AndrewKellerMD….
podcasts.apple.com
Podcast Episode · Listen to Gynecologic Oncology · 09/25/2024 · 18m
0
7
0
Congrats @LilieLinMD !!!.
Well deserved recognition for @LilieLinMD! Her work on gyn cancers impacts patients in US and worldwide. @MDAndersonNews #radonc #endcancer
0
0
7
Congrats @ColtonLadbury !.
Congrats to @COH_RadOnc and @cityofhopoc's @ColtonLadbury on receiving the inaugural @ASTRO_org ARRO Resident Educator of the Year Award! The award was presented to Dr. Ladbury at #ASTRO24, where he also received the 2024 Quick Pitch Recognition Award.
0
1
12
RT @ColtonLadbury: Congratulations to our own Dr Wong on his Phase II trial of 20 Gy TMLI with Cy and VP16. Truly a paradigm shift for thes….
0
4
0